Here are the 424B prospectus supplements from Texas Instruments Incorporated (TXN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow TXN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TXN filings page.
Texas Instruments Incorporated (TXN) is offering $2 billion aggregate principal amount of four unsecured senior note series: $500 million each of 5.000% notes due November 9, 2028, 5.350% notes due November 9, 2031, 5.500% notes due November 9, 2033, and 5.750% notes due November 9, 2036. Interest is payable semi-annually beginning May 9, 2027. TXN expects approximately $1.987 billion in net proceeds and intends to use them for part of the Silicon Labs acquisition purchase price and related fees and expenses. The acquisition is expected in the first half of 2027, subject to regulatory approvals and other customary closing conditions; the notes sale is not conditioned on the acquisition closing.
If specified events occur—including termination of the merger agreement, failure to complete the acquisition by the applicable deadline, or TXN’s determination that it will not be completed—the company must redeem all outstanding notes at 101% of principal plus accrued and unpaid interest. There is no escrow account or security interest in the proceeds for noteholders. The notes rank equally with TXN’s other unsecured and unsubordinated debt, but are effectively subordinated to subsidiary liabilities and secured debt.
Texas Instruments Incorporated is offering four series of senior unsecured notes, with terms subject to completion. It intends to use the net proceeds to finance part of the purchase price for Silicon Labs and pay related fees and expenses. The note sale is not conditioned on closing the acquisition. Under the merger agreement, Silicon Labs stockholders would receive $231.00 cash per share; the transaction has an approximately $7.5 billion enterprise value and is expected to close in the first half of 2027, subject to regulatory approvals and other customary conditions.
If specified acquisition failure events occur—including failure to close by the applicable deadline, termination of the merger agreement, or TI determining the acquisition will not be completed by the deadline or at all—TI must redeem all outstanding notes at 101% of principal plus accrued and unpaid interest. The notes are unsecured senior obligations that rank pari passu with TI’s other unsecured and unsubordinated debt, and are effectively subordinated to subsidiary liabilities and secured debt. As of September 30, 2026, TI reported approximately $17.7 billion in consolidated liabilities, including approximately $1.5 billion at subsidiaries to whose liabilities the notes are effectively subordinated.